Tislelizumab combined with chemotherapy or radiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (TINES): A randomized, open, phase II study

被引：0
|
作者：
Zhang, Yong
Che, Shaomin
Chen, Nanzheng
Li, Xinju
Fu, Junke
Yu, Chenao
Wang, Tianren
Liang, Runjia
Xu, Haozhen
Wu, Qifei
Jia, Zhuoqi
Zhu, Cailin
Gong, Tuotuo
Li, Haijun
Zhang, Boxiang
Hu, Yunyun
Liu, Yaqi
机构：
[1] Xi An Jiao Tong Univ, Dept Thorac Surg, Affiliated Hosp 1, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Radiat Oncol, Affiliated Hosp 1, Xian, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16090
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant Immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, controlled, open label, phase II clinical trial
    Liu, L.
    Li, Y.
    Chen, F.
    Zeng, Y.
    Xiang, Z-Z
    ANNALS OF ONCOLOGY, 2024, 35
  • [32] Neoadjuvant camrelizumab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, open-label study
    Wang, Jianping
    Zhang, Jian
    Gao, Jie
    Zhao, Mengmeng
    Ma, Zhenkai
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 33 (06): : 573 - 581
  • [33] Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcinoma: A pooled analysis of randomized clinical trials
    Yang, Yang
    Shao, Rongjun
    Cao, Xiufeng
    Chen, Mengyuan
    Gong, Wangang
    Ying, Hangjie
    Song, Ge
    You, Guangxian
    Qiu, Guoqin
    Chen, Qixun
    Ji, Yongling
    Xu, Dong
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [34] A phase II study of neoadjuvant chemotherapy with DCS for resectable advanced esophageal cancer
    Kitadani, Junya
    Nakamura, Masaki
    Ojima, Toshiyasu
    Katsuda, Masahiro
    Hayata, Keiji
    Yamaue, Hiroki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [35] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Ding, Chengzhi
    Guo, Yijun
    Zhou, Yaning
    He, Yi
    Chen, Chunji
    Zhang, Ming
    Guo, Xufeng
    BMC CANCER, 2023, 23 (01)
  • [36] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Chengzhi Ding
    Yijun Guo
    Yaning zhou
    Yi He
    Chunji Chen
    Ming Zhang
    Xufeng Guo
    BMC Cancer, 23
  • [37] Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma
    Leng, Xue-Feng
    Daiko, Hiroyuki
    Han, Yong-Tao
    Mao, You-Sheng
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1482 (01) : 213 - 224
  • [38] Neoadjuvant durvalumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC)
    He, J.
    Zhao, L.
    Li, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S1553 - S1553
  • [39] Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma: A Randomized Phase II Clinical Trial
    Yang, Y.
    Wang, C.
    Jiang, Y.
    Zhou, X.
    Wang, S.
    Su, D.
    Qiu, G.
    Chen, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S13 - S13
  • [40] Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma
    Yang, Guozhen
    Yue, Haodong
    Zhang, Xiaomin
    Zeng, Chufeng
    Tan, Linyu
    Zhang, Xu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345